share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144：拟议出售证券

SEC announcement ·  03/04 17:47
Moomoo AI 已提取核心信息
Arcutis Biotherapeutics, Inc. officer David W. Osborne is set to sell 4,255 shares of common stock on 03/04/2024, as per the latest filing. The shares to be sold were recently acquired through restricted stock vests on three separate dates: 882 shares on 03/03/2024, 2,618 shares on 03/01/2024, and 755 shares on 02/27/2024, all from Arcutis Biotherapeutics. The aggregate market value of the shares to be sold is reported at $47,320.81. There is no transaction history reported for the past three months prior to this notice.
Arcutis Biotherapeutics, Inc. officer David W. Osborne is set to sell 4,255 shares of common stock on 03/04/2024, as per the latest filing. The shares to be sold were recently acquired through restricted stock vests on three separate dates: 882 shares on 03/03/2024, 2,618 shares on 03/01/2024, and 755 shares on 02/27/2024, all from Arcutis Biotherapeutics. The aggregate market value of the shares to be sold is reported at $47,320.81. There is no transaction history reported for the past three months prior to this notice.
根据最新文件，Arcutis Biotherapeutics, Inc.高管戴维·奥斯本定于2024年4月3日出售4,255股普通股。拟出售的股票最近在三个不同的日期通过限制性股票背心收购：2024年3月3日收购了882股，2024年1月3日收购了2618股，2024年2月27日收购了755股，全部来自Arcutis Biotherapeutics。据报道，待售股票的总市值为47,320.81美元。在此通知之前的过去三个月中，没有报告任何交易历史记录。
根据最新文件，Arcutis Biotherapeutics, Inc.高管戴维·奥斯本定于2024年4月3日出售4,255股普通股。拟出售的股票最近在三个不同的日期通过限制性股票背心收购：2024年3月3日收购了882股，2024年1月3日收购了2618股，2024年2月27日收购了755股，全部来自Arcutis Biotherapeutics。据报道，待售股票的总市值为47,320.81美元。在此通知之前的过去三个月中，没有报告任何交易历史记录。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息